Shares of Merus NV (NASDAQ: MRUS) rose sharply in today’s pre-market trading.
Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.
Merus shares jumped 38.2% to $95.21 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Steakholder Foods Ltd – ADR (NASDAQ: STKH) rose 92% to $8.32 in pre-market trading. Steakholder Foods recently announced signing of agreement for the acquisition of Twine Solutions.
- JFB Construction Holdings (NASDAQ: JFB) surged 77.4% to $12.15 in pre-market trading after the company announced a $44 million private placement.
- Plus Therapeutics Inc (NASDAQ: PSTV) gained 24.3% to $0.77 in pre-market trading after gaining 10% on Friday. Plus Therapeutics recently announced a national coverage agreement with UnitedHealthcare for its CNSide cerebrospinal fluid assay for metastatic CNS cancer.
- Avalo Therapeutics Inc (NASDAQ: AVTX) rose 24.1% to $13.40 in pre-market trading after falling 6% on Friday.
- Enanta Pharmaceuticals Inc (NASDAQ: ENTA) gained 22.7% to $9.69 in pre-market trading after the company announced it will present topline results from its Phase 2b study of Zelicapavir for RSV in high-risk adults on Monday.
- Canopy Growth Corp (NASDAQ: CGC) jumped 19.4% to $1.60 in pre-market trading.
- Zura Bio Ltd (NASDAQ: ZURA) gained 18.3% to $2.85 in pre-market trading after jumping 15% on Friday.
- Tilray Brands Inc (NASDAQ: TLRY) surged 17.4% to $1.35 in pre-market trading. Tilray Brands will announce first quarter financial results on Oct. 9.
- Larimar Therapeutics Inc (NASDAQ: LRMR) jumped 16.4% to $5.93 in pre-market trading. Larimar will issue Nomlabofusp program update for Friedreich’s Ataxia during conference call and webcast on Sept. 2.
Losers
- MoonLake Immunotherapeutics (NASDAQ: MLTX) dipped 86.3% to $8.50 in pre-market trading. MoonLake’s Phase 3 VELA trials showed Sonelokimab achieved statistically significant HiSCR75 responses in moderate to severe hidradenitis suppurativa.
- Maris Tech Ltd (NASDAQ: MTEK) fell 37.3% to $2.62 in pre-market trading. Maris Tech posted a H1 loss of 30 cents per share.
- Sunrise New Energy Co Ltd (NASDAQ: EPOW) shares dipped 28.1% to $0.88 in pre-market trading. Sunrise New Energy shares gained 10% on Friday after the company announced plans for a 1GW U.S. lithium battery pack project.
- Cycurion Inc (NASDAQ: CYCU) declined 15.5% to $0.28 in pre-market trading after dipping more than 30% on Friday.
- bioAffinity Technologies Inc (NASDAQ: BIAF) dipped 14.4% to $4.53 in pre-market trading. bioAffinity Technologies shares jumped 55% on Friday after the company announced that it released three additional case studies, with one case study demonstrating that CyPath Lung led to detecting Stage 1A lung cancer.
- Youxin Technology Ltd (NASDAQ: YAAS) fell 13.9% to $0.058 in pre-market trading. Youxin Technology announced a 1-for-80 reverse split to regain Nasdaq compliance, effective Sept. 30.
- Top KingWin Ltd (NASDAQ: WAI) fell 12.8% to $4.07 in the pre-market trading. Top KingWin shares jumped 48% on Friday after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of TK-D2C AI Robots.
- Cellectis SA (NASDAQ: CLLS) declined 10.4% to $3.01 in pre-market trading.
- Quantum-Si Inc (NASDAQ: QSI) fell 10.1% to $1.34 in pre-market trading. Quantum-Si filed for mixed shelf of up to $300 million.
- Penguin Solutions Inc (NASDAQ: PENG) fell 8.4% to $24.00 in pre-market trading.
Now Read This:
Photo via Shutterstock
